ArticleThe Journal of biological chemistry2026
Engineering human RNase 7 with an eosinophil RNase segment reveals determinants of cytotoxic and antimicrobial activity.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human ribonuclease 7 is a potent antimicrobial member of the RNase A superfamily with little cytotoxic activity, in contrast to the closely related eosinophil cationic protein (HsR3). To determine which structural elements underlie these divergent functions, we engineered a chimeric RNase 7 variant in which loop 4 to 5 residues 61 to 77 were replaced by the corresponding segment from HsR3. This chimera acquired cytotoxicity toward HeLa cells while retaining antibacterial activity against Escherichia coli and Mycobacterium smegmatis, identifying this segment as a key transferable determinant of RNase function. Consistent with this result, a peptide spanning HsR3 residues 61 to 77 also displayed antibacterial activity, supporting a direct contribution of this region to host-defense activity and functional modulation within the RNase scaffold. To define the structural basis of RNase 7 activity, we determined crystal structures of RNase 7 in apo and 5'-AMP-bound forms and combined these with NMR titrations and molecular docking. These analyses revealed a canonical RNase fold together with an unexpected adenine-binding pose in the B
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.